Cancer Vaccine Combo a 'Potential Major Breakthrough' in Skin Cancer
The addition of a personalized cancer vaccine to Keytruda led to a 44% reduction in the risk of death or recurrence in certain patients with melanoma.
United States Ryan Sullivan Jeffreys Weber Grossman School Of Medicine Harvard Medical School Cancer Center
Source: curetoday.com